# ONDANSETRON AND EFFECTIVE DOSE IN 50% OF SUBJECTS OF PROPHYLACTIC NOREPINEPHRINE INFUSIONS FOR PREVENTING SPINAL ANESTHESIA-INDUCED HYPOTENSION DURING CESAREAN DELIVERY

> **NCT04703088** · PHASE3 · UNKNOWN · sponsor: **Laval University** · enrollment: 60 (estimated)

## Conditions studied

- Hypotension
- Anesthesia; Adverse Effect, Spinal and Epidural
- Cesarean Section

## Interventions

- **DRUG:** Ondansetron 4 MG
- **DRUG:** 0.9% Saline

## Key facts

- **NCT ID:** NCT04703088
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703088, "ONDANSETRON AND EFFECTIVE DOSE IN 50% OF SUBJECTS OF PROPHYLACTIC NOREPINEPHRINE INFUSIONS FOR PREVENTING SPINAL ANESTHESIA-INDUCED HYPOTENSION DURING CESAREAN DELIVERY". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04703088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*